Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

908 Devices’ Research Partner Presents Research on Mass Spectrometry

Published: Friday, August 16, 2013
Last Updated: Friday, August 16, 2013
Bookmark and Share
Advancing the rapidly evolving field of High Pressure Mass Spectrometry.

908 Devices continues to benefit from its research partnership with the group of Prof. J. Michael Ramsey at the University of North Carolina at Chapel Hill (UNC-CH).

The Ramsey team made a total of eight research presentations at the American Society of Mass Spectrometry Conference in June, all advancing the rapidly evolving field of High Pressure Mass Spectrometry (HPMS™).

The UNC-CH presentations covered substantial advances in both the theoretical understanding and practical performance of miniature ion traps, ionizers and detectors at operating pressures up to, and beyond, 1 torr - HPMS™.

Multiple presentations explored the theoretical attributes of ion trajectories as a function of trap fabrication geometries and drive parameters.

One of the most exciting areas of research involves a new stretched length ion trap geometry that experimentally demonstrated a near order-of-magnitude increase in ion-trapping capacities compared to cylindrical geometries.

Further, a presentation on the influence of drive frequency demonstrated sub-amu resolutions from miniature ion trap arrays operating in the HPMS regime.

908 Devices has exclusive license to a broad portfolio of patents developed by the research team at the University that contributes to the design and manufacture of simple-to-operate, ultra-compact chemical detection and analysis tools.

The HPMS™ projects presented by the Ramsey group received support from the US Department of Defense (DOD) signifying the value placed on these capabilities by the safety and security community.

Dr. Chris Brown, Co-founder and CTO of 908 Devices highlighted the impressive nature of the research presented by saying, “The Ramsey group at UNC-CH has a large, focused and productive effort in the field of miniaturized mass spectrometry. Collaboration between our teams continues to be mutually beneficial and we are extremely excited about working together to successfully bring the powerful capabilities of mass spectrometry out of the laboratory into the hands of the first responder.”

These HPMS developments are crucial to the successful creation of highly sensitive and selective miniaturized mass spectrometry tools by 908 Devices.

The initial product focus is on safety and security markets, but the broad platform of 908 Devices’ simple, rugged and cost-effective MS analyzers will address customer problems across diverse markets.

The UNC-CH research team is led by Professor J. Michael Ramsey, who is the Minnie N. Gold by Distinguished Professor of Chemistry in UNC-CH’s College of Arts and Sciences, at the University with additional multiple appointments in the UNC-CH School of Medicine.

Prof. Ramsey is also a co-founder of 908 Devices, a member of its Board of Directors and the Science Founder of Caliper Life Sciences.

“Our presentations outlined clearly a number of innovative advances in miniaturized mass spectrometry, a dynamic field with myriad practical applications outside the lab,” said Prof. Ramsey.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

908 Devices Announces Significant Milestones
Company has expanded its office from a 7,000 square-foot R&D think tank into a 16,000 square-foot full-scale production facility.
Wednesday, August 20, 2014
908 Devices Receives $7 Million in Series B Funding
The financing round will be used to expand the R&D team and to accelerate and commercialize 908 Devices’ initial safety and security products.
Wednesday, September 11, 2013
Scientific News
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
How Skeletal Stem Cells Form The Blueprint Of The Face
USC researchers discover that two types of molecular signals work to control where and when stem cells turn into facial cartilage.
Intestinal Worms Boost Immune System In A Surprising Way
EPFL researchers find that intestinal worm infections cause lymph nodes to produce more immune cells as well as grow in size.
Measuring The Airborne Toxicants Urban Bicyclists Inhale
Researchers analyze breath biomarkers to measure uptake of volatile organic compounds by bicyclists.
Breast Milk Hormones Impact Bacteria In Infants’ Guts
Intestinal microbiome of children born to obese mothers significantly different from those born to mothers of healthy weight, CU Anschutz researchers find.
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
New Method Allows First Look At Embryo Implantation
Researchers at The Rockefeller University develop a method that shows the molecular and cellular processes that occur up to day 14 after fertilization.
Shining A Light On Bladder Cancer
Researchers scrutinize patterns of mutations in bladder tumor genomes, gleaning insights into the roles of DNA repair and tobacco-related DNA damage.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!